Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

2.42
Delayed Data
As of 1:53pm ET
 +0.025 / +1.04%
Today’s Change
1.76
Today|||52-Week Range
6.69
-6.01%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close2.40
Today’s open2.40
Day’s range2.30 - 2.45
Volume369,368
Average volume (3 months)272,908
Market cap$57.9M
Dividend yield--
Data as of 1:53pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)+56.50%
Earnings growth (this year)0.00%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+77.69%
P/E ratioNM
Price/Sales1.20
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EBIOEleven Biotherapeuti...+0.08+3.35%
NVETNexvet Biopharma plc-0.25-5.06%
MEIPMEI Pharma Inc0.000.00%
JNPJuniper Pharmaceutic...0.000.00%
Data as of 1:56pm ET, 12/05/2016

Financials

Next reporting dateMarch 13, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$51.2M
Annual profit (last year)-$16.3M
Net profit margin-31.93%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs